108 related articles for article (PubMed ID: 32589499)
1. Transferrin receptors targeting peptide (T7 peptide) surface-modified sorafenib nanoliposomes enhance the anti-tumor effect in colorectal cancer.
Wang S; Sun H
Pharm Dev Technol; 2020 Nov; 25(9):1063-1070. PubMed ID: 32589499
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary delivery of transferrin receptors targeting peptide surface-functionalized liposomes augments the chemotherapeutic effect of quercetin in lung cancer therapy.
Riaz MK; Zhang X; Wong KH; Chen H; Liu Q; Chen X; Zhang G; Lu A; Yang Z
Int J Nanomedicine; 2019; 14():2879-2902. PubMed ID: 31118613
[No Abstract] [Full Text] [Related]
3. A stabilized retro-inverso peptide ligand of transferrin receptor for enhanced liposome-based hepatocellular carcinoma-targeted drug delivery.
Tang J; Wang Q; Yu Q; Qiu Y; Mei L; Wan D; Wang X; Li M; He Q
Acta Biomater; 2019 Jan; 83():379-389. PubMed ID: 30395963
[TBL] [Abstract][Full Text] [Related]
4. Inhalable nanostructured lipid particles of 9-bromo-noscapine, a tubulin-binding cytotoxic agent: in vitro and in vivo studies.
Jyoti K; Kaur K; Pandey RS; Jain UK; Chandra R; Madan J
J Colloid Interface Sci; 2015 May; 445():219-230. PubMed ID: 25622047
[TBL] [Abstract][Full Text] [Related]
5. Enhanced blood-brain barrier penetration and glioma therapy mediated by T7 peptide-modified low-density lipoprotein particles.
Liang M; Gao C; Wang Y; Gong W; Fu S; Cui L; Zhou Z; Chu X; Zhang Y; Liu Q; Zhao X; Zhao B; Yang M; Li Z; Yang C; Xie X; Yang Y; Gao C
Drug Deliv; 2018 Nov; 25(1):1652-1663. PubMed ID: 30394123
[TBL] [Abstract][Full Text] [Related]
6. Peptide-conjugated PAMAM for targeted doxorubicin delivery to transferrin receptor overexpressed tumors.
Han L; Huang R; Liu S; Huang S; Jiang C
Mol Pharm; 2010 Dec; 7(6):2156-65. PubMed ID: 20857964
[TBL] [Abstract][Full Text] [Related]
7. Decreasing acute toxicity and suppressing colorectal carcinoma using Sorafenib-loaded nanoparticles.
Li N; Chen Y; Sun H; Huang T; Chen T; Jiang Y; Yang Q; Yan X; Wu M
Pharm Dev Technol; 2020 Jun; 25(5):556-565. PubMed ID: 31958240
[No Abstract] [Full Text] [Related]
8. A pH-sensitive T7 peptide-decorated liposome system for HER2 inhibitor extracellular delivery: an application for the efficient suppression of HER2+ breast cancer.
Zhang S; Sun Q; Peng X; Gan N; Zhao L; Suo Z; Zhao G; Li H
J Mater Chem B; 2021 Nov; 9(42):8768-8778. PubMed ID: 34585713
[TBL] [Abstract][Full Text] [Related]
9. Development of synthetic of peptide-functionalized liposome for enhanced targeted ovarian carcinoma therapy.
Wu H; Yao L; Mei J; Li F
Int J Clin Exp Pathol; 2015; 8(1):207-16. PubMed ID: 25755707
[TBL] [Abstract][Full Text] [Related]
10. Peptide T7-modified polypeptide with disulfide bonds for targeted delivery of plasmid DNA for gene therapy of prostate cancer.
Lu Y; Jiang W; Wu X; Huang S; Huang Z; Shi Y; Dai Q; Chen J; Ren F; Gao S
Int J Nanomedicine; 2018; 13():6913-6927. PubMed ID: 30464450
[TBL] [Abstract][Full Text] [Related]
11. RGD-decorated nanoliposomes for combined delivery of arsenic trioxide and curcumin to prostate cancer cells.
Khosravani F; Amiri F; Mahmoudi R; Morshedi D; Kobarfard F; Alipour M; Hosseini E; Bardania H
Naunyn Schmiedebergs Arch Pharmacol; 2024 Apr; 397(4):2347-2357. PubMed ID: 37831114
[TBL] [Abstract][Full Text] [Related]
12. Coating of betanin and carvone Co-loaded nanoliposomes with synthesized cationic inulin: A strategy for enhancing the stability and bioavailability.
Amjadi S; Almasi H; Hamishehkar H; Alizadeh Khaledabad M; Lim LT
Food Chem; 2022 Mar; 373(Pt A):131403. PubMed ID: 34710692
[TBL] [Abstract][Full Text] [Related]
13. Tumor RNA-loaded nanoliposomes increases the anti-tumor immune response in colorectal cancer.
Dai D; Yin Y; Hu Y; Lu Y; Zou H; Lu G; Wang Q; Lian J; Gao J; Shen X
Drug Deliv; 2021 Dec; 28(1):1548-1561. PubMed ID: 34286631
[TBL] [Abstract][Full Text] [Related]
14. Multifunctional pH-sensitive polymeric nanoparticles for theranostics evaluated experimentally in cancer.
Liu Y; Feng L; Liu T; Zhang L; Yao Y; Yu D; Wang L; Zhang N
Nanoscale; 2014 Mar; 6(6):3231-42. PubMed ID: 24500240
[TBL] [Abstract][Full Text] [Related]
15. Intranasal Delivery of Carvedilol- and Quercetin-Encapsulated Cationic Nanoliposomes for Cardiovascular Targeting: Formulation and
Kar S; Das SS; Kundu S; Sahu BD; Kumar KJ; Kesari KK; Singh SK
ACS Appl Bio Mater; 2024 May; 7(5):3061-3085. PubMed ID: 38581388
[TBL] [Abstract][Full Text] [Related]
16. Glycyrrhetinic Acid and TAT Peptide Modified Dual-functional Liposomes for Treatment of Hepatocellular Cancer.
Huang S; Ren D; Wu X; Li M; Yu X; Nie X; Wang Y; Wang Y
Curr Top Med Chem; 2020; 20(27):2493-2505. PubMed ID: 32703132
[TBL] [Abstract][Full Text] [Related]
17. Dual targeted nanocarrier for brain ischemic stroke treatment.
Zhao Y; Jiang Y; Lv W; Wang Z; Lv L; Wang B; Liu X; Liu Y; Hu Q; Sun W; Xu Q; Xin H; Gu Z
J Control Release; 2016 Jul; 233():64-71. PubMed ID: 27142584
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of dual-functional liposomes containing paclitaxel for treatment of lung cancer.
Wang RH; Cao HM; Tian ZJ; Jin B; Wang Q; Ma H; Wu J
Oncol Rep; 2015 Feb; 33(2):783-91. PubMed ID: 25482610
[TBL] [Abstract][Full Text] [Related]
19. RGD-modified pH-sensitive liposomes for docetaxel tumor targeting.
Chang M; Lu S; Zhang F; Zuo T; Guan Y; Wei T; Shao W; Lin G
Colloids Surf B Biointerfaces; 2015 May; 129():175-82. PubMed ID: 25851582
[TBL] [Abstract][Full Text] [Related]
20. Furin-responsive triterpenine-based liposomal complex enhances anticervical cancer therapy through size modulation.
Chen Y; Guo M; Qu D; Liu Y; Guo J; Chen Y
Drug Deliv; 2020 Dec; 27(1):1608-1624. PubMed ID: 33179521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
